Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality

By  

Current Vascular Pharmacology, Vol. 16, Iss. 3, 2018-03 ,pp. : 206-208

Bentham Science Publishers

Access to resources Recommend Favorite

All-Cause Mortality and Liver-Related Outcomes Following Successful Antiviral Treatment for Chronic Hepatitis C

By Dieperink Eric   Pocha Christine   Thuras Paul   Knott Astrid   Colton Samuel   Ho Samuel  

Digestive Diseases and Sciences, Vol. 59, Iss. 4, 2014-04 ,pp. : 872-880

Springer Publishing Company

Access to resources Recommend Favorite

Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)

By Catalano Daniela   Martines Giuseppe   Tonzuso Antonia   Pirri Clara   Trovato Francesca   Trovato Guglielmo  

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3200-3206

Springer Publishing Company

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease

By Björnsson Einar   Angulo Paul  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 9, 2007-01 ,pp. : 1023-1030

Informa Healthcare

Access to resources Recommend Favorite

Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial

By Haukeland John Willy   Konopski Zbigniew   Eggesbø Heidi Beate   von Volkmann Hilde Løland   Raschpichler Gabriele   Bjøro Kristian   Haaland Terese   Løberg Else Marit   Birkeland Kåre  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 853-860

Informa Healthcare

Access to resources Recommend Favorite